HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis.

Abstract
Despite the proven efficacy of low-dose pamidronate in adults with osteoporosis, the efficacy of the low-dose regimen in children has not been studied. Pamidronate (1 mg/kg) was administered intravenously once every 3 months to 11 children with osteoporosis. Treatment was associated with reduced fracture rates and increased areal (BMD) and volumetric (BMAD) bone mineral density measured by dual energy X-ray absorptiometry (DXA). The mean annualized percent gain was 20.1 +/- 16.9 (4.7 to 59.1, n = 9) for spinal BMD and 15.1 +/- 18.1 (-11.0 to 40.2, n = 9) for spinal BMAD. Common adverse effects including fever, muscle aches, nausea and fatigue were self-limited and generally occurred only after the first infusion. Clinically significant hypocalcemia did not occur. Low-dose pamidronate appears promising in the treatment of childhood osteoporosis.
AuthorsLaura M Gandrud, Jennifer C Cheung, Mark W Daniels, Laura K Bachrach
JournalJournal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) 2003 Jul-Aug Vol. 16 Issue 6 Pg. 887-92 ISSN: 0334-018X [Print] England
PMID12948302 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Diphosphonates
  • Hormones
  • pamidronate
  • Calcium
Topics
  • Absorptiometry, Photon
  • Adolescent
  • Anti-Inflammatory Agents (administration & dosage, adverse effects, therapeutic use)
  • Bone Density (drug effects)
  • Calcium (blood)
  • Child
  • Diphosphonates (administration & dosage, adverse effects, therapeutic use)
  • Female
  • Fractures, Bone (epidemiology, prevention & control)
  • Growth (drug effects)
  • Hormones (blood)
  • Humans
  • Injections, Intravenous
  • Male
  • Osteoporosis (complications, drug therapy)
  • Weight Gain (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: